1.Practice Committee of the American Society for Reproductive Medicine. Myomas and reproductive function. Fertil Steril. 2004;82 Supp 1: 111-6. 2.Bukulmez O, Doody KJ. Clinical Features of Mayomas. Obstet Gynecol Clin N Am. 2006; (33): 69-94 3.Quintela AM, Franquiz P, Fernández JI, Trinas ME, Peláez O, Hernández M. Estudio de algunos parámetros bioquímicos y de la actividad angiogénica del omento. Rev Cubana Invest Biomed. 1997; 16(2):105-10. 4.Cortesini R. Stem Cell, tissue engineering and organogenesis in transplantation. Transpl Immunol. 2005;15(2):81-9. 5.Soo Won S, Jinhoom K, Jiyoun S, Kwa N, Kwanghyun K, Hojoon GK, et al. Use of omentum as an in vivo cell cultured system in tissue engineering. ASAIO J. 2004;50(5):464-7. 6.García-Gómez I, Goldsmith HS, Angulo I, Prado A, López-Hervas P, Cuevas B. Angiogenic capacity of human omental Stem Cell. Neurol Res. 2005;27(8):807-11. 7.Tietze L, Borntraeger J, Klosterhalfen B, Amo-Takyi B, Handt S, Gunther K, et al. Expression and function of beta(1) and beta (3) integrins of human mesothelial cell in vitro. Exp Mol Pathol. 1999;66(2):131-9. 8.Bittinger F, Brochhausen C, Skarke C, Kohler H, Kirkpatrick CJ. Reconstruction of peritoneal-like structure in three dimensional collagen gel matrix culture. Exp Cell Res. 1997;236(1):155-60. 9.Moriya K, Kakisaki H, Murakumo M. Creation of luminal tissue covered with urothelium by implantation of culture urothelial cells into the peritoneal cavity. J Urol. 2003;170:2480-5. 10.Hultman CS, Carlson GW, Losken A, Jones G, Culbertson J, Mackay G, et al. Utility of the omentum in the reconstruction of complex extraperitoneal wounds and defects. Donor site complication in 135 patients from 1975 to 2000. Ann Surg. 2002;235(6):782-95. 11.Goldsmith HS, Wu W, Zhong J, Edgar M. Omental transposition to the brain as a surgical method for treating AIzheimer´s disease. Neurol Res. 2003;25(6):625-34. 12.Goldsmith HS. Treatment of Alzheimer´s disease by transposition of the omentum. Ann NY Acad Sci. 2002;997:454-67. 13.Goldsmith HS, Sax DS. Omental transposition for cerebral infartion: a 13 year fallow op study. Sur Neurol. 1999;51(3):342-6. 14.Goldsmith HS, Fonseca A, Porter J. Spinal cord separation: MRI evidence of healing after omentum-collagen reconstruction. Amn NY Acad Sci. 2005;27(2):115-23. 15.Yohizaki T, Maekawa K, Tukatami T, Shibutani K, Nishimura T, Omura K, et al. Bilateral jejunomesenteric flap for reconstruction of complicated pharyngoesophageal defect. Am J Surg. 2000;179(6):497-9. 16.Lorenz RR, Alam DS. The increasing use of omental flap in reconstruction for the upper aerodigestive tract. Curr Opin Otolaryngol Head Neck Surg. 2003; 11(4): 230-5. 17.Nishimura T, Yamada K, Ito M, Miwa T, Furukawa M. Head and neck reconstruction using laparoscopically havested omentum. Nippon Jibiikoka Gakkai Kaiho. 2004;107(6):658-64. 18.Nishimaki T, Ono K, Tada T, Hatekeyama K. Successful primary reinforced repair of esophangeal perforation using a pedicle omental graft through a transhiatal approach. Dis Esophagus. 2001;14(2):155-8. 19.Morishita Y. Omentoplasty versus no omentoplasty for cervical esophogogastrotomy following radical esophagectomy. Hephatogastroentorology. 2002;49(43):181-4. 20.Thakur B, Zhang CS, Tan ZB. Omentoplasty for esophogastrotomy after surgery for cancer of cardia and esophagus. Indian J Cancer. 2004;41(4):167-9. 21.Agnifili A, Schietroma M, Carloni A, Mattucci S, Caterino G, Carlei F. Omentoplasty is effective in lowering the complications of ano-rectal resection. Minerva Chir. 2004;59(4):363-8. 22.Shrager JB, Wain JC, Wright CD, Donahue DM, Vlahakes GJ, Moncure AC, et al. Omentum is highly effective in the management of complex cardiothoracic surgical problems. J Thorac Cardiovasc Surg. 2003;125(3):526-32. 23.Park C, Roh TS, Chi HS. Total ear reconstruction in the desvascularized temporoparietal region: II use of the omental free flap. Plast Reconst Surg. 2003;111(4):1391-7. 24.Losken A, Carlson GW, Culbertson JH, Scott Hultman C, Kumar AV, Jones GE. Omental free flaps reconstruction in complex head and neck deformities. Head Neck. 2002;24(4):326-31. 25.Svebis M, Pap-Szekeres J, Venczel L, Gera L, Rajtar M, Sinko M. Early clinical experience with posoperative monitoring of a patient after laparoscopic splenectomy combined with spleen autotransplantation (a case report). Magy Seb. 2005; 58(2): 80-3. 26.Acs G, Furka I, Miko I, Szendroi T, Hajdc Z, Sipka S, Barath S. Comparative hematologic and immunologic studies of patients with splenectomy and spleen autotransplantation. Magy Seb. 2005;58(2):74-9. 27.Mederos Guzmán T, Sierra Enrique E. Cirugía conservadora del bazo en el niño y el adulto. En: Sierra Enrique E. Cirugía del bazo. Colombia: Corporación Educativa Superior; 2004. p. 155-74. 28.Sharma D, Saxena A, Rahaman H, Raina VR, Kapoor JP. Free omental plug a nostalgic look at an old and dependable technique for giant pectic perforation. Dig Surg. 2000;17(3):216-8. 29.Dudderidge TJ, Hayness SV, Davies AJ, Jarmulowiez M, Al-Akraa MA. Vesico cervical fistula: rare complication of cesarean section demonstrated by magnetic resonance imaging. Urology. 2005;65(1):174. 30.Sapmaz E, Celik H, Semercioz A. Omental graft use in Youssef syndrome. Eur J Obstet Gynecol Reprod Biol. 2003;109(1):92-6. 31.Hernández Ramírez P. Medicina regenerativa ll. Aplicaciones, realidad y perspectivas de la terapia celular. Rev Cubana Hematol Inmunol Hemoter [serie en Internet]. 2006 [6 Mar 2006]; 22(1):[aprox. 9 p.]. Disponible en: http://bvs.sld.cu/revistas/h.h/vol22_06/h.h02116.htm 32.Verfaile CM, Pera MF, Lansdorn PM. Stem cells: hype and reality. Hematology. 2002;1:369-91. 33.Rosenthal N. Prometheus´s culture and the stem-cell promise. N Engl J Med. 2003;349:267-74. 34.Cuba. Ministerio de Salud Pública. Salud reproductiva. En: Manual de diagnóstico y tratamiento de obstetricia y perinatología. La Habana: Ciencias Médicas; 2000. p.17-21. 35.González Pérez U, Gravallo J, Amarillo Mendoza M. La calidad de vida como problema de la bioética en la salud humana. En: Acosta Sariego JR. Bioética desde una perspectiva cubana. 2da ed. La Habana: Centro Félix Varela; 1998. p. 141-7. 36.Velardo de Jurado E, Ávila Figueroa C. Evaluación de la calidad de vida. Salud Pública Mex. 2002;44:349-61. 37.Selman Housein Abdo E. Guía de acción para la excelencia en la atención médica. La Habana: Científico Técnica; 2002. 38.Rock JA, Thompson JD. Leiomiomas uterinos y miomectomía. En: Te Linde ginecología quirúrgica. Madrid: Médica Panamericana; 2006. p. 751-92. 39.Rodríguez Hidalgo N. Mioma uterino. En: Cirugía laparoscópica ginecológica. Madrid: SSAG SL; 1999. p. 475-82. 40.Chelmow D, Lee S, Evantash E. Gynecology myomectomy [database on the Internet]. Cocrhane Database Syst Rev. c 2006 [update 2006 Nov 20; cited 2006 Nov 23]. Available from: http://www.emedicine/topic3319.htm 41.Payson M, Leppert P, Segar J. Epidemiology of Mayoma. Obstet Gynecol Clin N Am. 2006; (33): 1-11 42.Brahma PK, Martel K, Ghristman GM, Future Directions in Mayoma Research. Obstet Gynecol Clin N Am. 2006; (33): 199-224 43.Saavedra J. Miomatosis uterina e infertilidad. Rev Colomb Obstet Ginecol. 2003;54(2):110-8. 44.Spies JB. New trends in the management of uterine fibroid presented at 3rd . Congress on controversies in obstetrics. Ginecology & infertility [monograph on the Internet]. Washington. DC; 2003 [cited 2006 Feb 2]. Available from: http://www.medscape.com/viewarticle/438448 45.Sinclair D, Gaither K, Mason TC. Fertility outcome following myomectomy in an urban hospital setting. J Natl Med Assoc. 2005;97(10):1346-8. 46.Wallach EE, Vlahos NF. Uterine myomas an overview of development clinical features, and management. Obstet Gynecol. 2004;104(2):393-406. 47.Ouyan D, Economi KT, Norwitz E. Obstetric Complications of Fibroids. Obstet Gynecol Clin N Am. 2006 (33): 153-169. 48.Bulleti C, De Zieder D, Levi Setti P, Cicinelli E, Polli V, Stefanetti M. Myomas, pregnancy outcome and in vitro fertilization. Amn NY Acad Sci. 2004;1034:84-92. 49.Bulleti C, De Zieder D, Polli V, Flamini C. The role of leiomyomas in infertility. J Am Assoc Gynecol Laparosc. 1999;6(2):441-5. 50.Paya V, Coloma F, Diago JV, Costa S, López Olmo J, Abad A, et al. Miomas y fertilidad tratamiento endoscópicos. Rev Iberoam Infertil. 2001;18(1):37-45. 51.Tulandi T. Laparoscopy vs laparotomy for myomectomy. Program and abstracts world from the 3er .Congress on controversies in obstetrics. Ginecology & infertility [monograph on the Internet]. Washington. DC; 2003 [cited 2006 Feb 2]. Available from: http://www.medscape.com/viewarticle/438448 52.Lefebve G, Vilos G, Allaire C, Jeffrey J, Araneja J, Birsch C. The management of uterine leiomyomas clinical practice gynecology committee society for obstetrician and gynecologysts of Canada. J. Obstet Gynecol Can. 2003;25(5):396-418. 53.Murakami T, Tamura M, Ozawa Y, Suzuki H, Terada Y, Okamura K. Safe techniques in surgery for hysteroscopic myomectomy. J Obstet Gynecol Res. 2005;31(3):216-23. 54.Gravello L, Agostini A, Beerli M, Roger V, Breteller F, Blanc B. Result of hysteroscopic myomectomy. Gynecol Obstet J Fertil. 2005;32(9):825-8. 55.Shokeir TA. Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet. 2005;273(1):50-4. 56.Varcellini P, Zaina B, Yaylayan L. Histeroscopic myomectomy: long-term effect on menstrual pattern and fertility. Obstet Gynecol. 1999;94(3):341-7. 57.Nair S. Contemporary management of fibroids. Ann Acad Med Singapore. 2003;35(5):615-23. 58.Batra N, Khunda A, O´ Donoban PJ. Hysteroscopic myomectomy. Obstet Gynecol North Am. 2004;31(3):669-85. 59.Olive LD, Linthein SR, Pristts E. Conservative Surgical Management of Uterine Mayoma. Obstet Gynecol Clin N Am. 2006; (33): 115-124. 60.Dubuisson JB, Frauconnier A, Deffages JV, Notgard C, Kreiker G, Chapron C. Pregnancy outcome and deliveries following laparoscopic myomectomy. Hum Reprod. 2000;15(4):869-73. 61.Dubuisson JB, Chapron C, Fauconnier A, Babaki–Fard K. Laparoscopic myomectomy fertility results. Amn NY Acad Sci. 2001;943:269-75. 62.Leng J, Lang J, Liu Z, Huang R. Laparoscopy myomectomy. Chin Med Sci J. 2001;16(2):111-4. 63.Advincula AP, Song A. Endoscopic management of leomyomata. Semin Reprod Med. 2004;22(22):149-55. 64.Hurst BS, Matthews ML, Marshburn PB. Laparoscopic myomectomy for syntomatic uterine myomas. Fertil Steril. 2005;83(1):1-23. 65.Thompson RD, William R. Control de hemorragias pelvianas. En: Te Linde ginecología quirúrgica. Madrid: Médica Panamericana; 2006. p. 205-41. 66.Zarlug G, Akar ME, Seker-Ari E, Yilmaz S, Sindel T. Uterine artery embolization to control bleeding after myomectomy. Acta Obstet Gynecol Scand. 2005; 84(66): 606-7. 67.Jacob D, Rafii A. Embolization of uterine arteries for uterine fibroids state of the art. Gynecol Obstet Fertil. 2005;33(6):454. 68.Ngeh N, Belli AM, Morgan R, Mayonda I. Pre myomectomy uterine artery embolization minimises operative blood loss. BJOG. 2004;11(10):1139-40. 69.Fauconier A, Pelageb JP, Lamcobe P, Villea Y. Embolization of uterine fibroids and infertility: is a clinical trial conceivable?. Gynecol Obstet Fertil. 2004;32(9):818-24. 70.Society of Obstetrician and Gynecologyts of Canada. SOGG. Clinical practice guidelines uterine fibroids embolization (UFE). Int Gynecol. 2005;85(3):305-18. 71.Goldberg J, Pereira L, Berghella V, Diamond J, Darai E, Seinera L, et al. Pregnancy utcome after treatment for fibromyomata: uterine artery embolization versus laparoscopic. Am J Obstet Gynecol. 2004;191(1):18-21. 72.Murgos S, Simon P, Golzaria J. Embolization of uterine fibroid. Rev Med Brus. 2002;23(5):435-43. 73.Marshburn PB, Mattheus ML, Hursts BS. Uterine Artery Embolization as a Treatment Option for uterine Mayoma. Obstet Gynecol Clin N Am. 2006; (33): 125-144. 74.Grupta J, Sinha A, Lumsden M, Hickey M. Uterine artery embolization for syntomatic uterine fibroids. [database on the Internet]. Cocrhane Database Syst Rev. c 2006 [update 2006 Feb 21; cited 2006 Nov 23]. Available from: http://www.emedicine.com/med/topic3318.htm 75.Agency for Health Care researsch and quality: management of uterine fibroids Summary Evidence Report [article on the Internet]. 2006 [cited 2006 Mar 6];[about 7 p.]. Available from: http://www.ahrq.gov/clinic/epcsums/uterusumn.htm 76.Lethaby A, Vollenhoven B, Sowter M. Pre-operative Gn-Rh analogue therapy before hysterectomy or myomectomy for uterine fibroids. [database on the Internet]. Cocrhane Database Syst Rev. c 2006 [update 2006 Feb 21; cited 2006 Mar 18]. Available from: http://www.emedicine.com/med/topic3317.htm 77.Rackow BW, Arici A. Options for Medical Treatment of Mayoma. Obstet Gynecol Clin N Am. 2006; (33): 97-113. 78.Olive DL, Lindheim SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol. 2004;16(3):239-43. 79.Campo S, Campo V, Gambadauro P. Short-term and long-term results of resectoscopic myomectomy with and without pre-treatment with Gn-Rh analogs in premenopausal women. Acta Obstet Gynecol Scand. 2005;84(8):756-60. 80.Seracchioli R, Venturoli S, Colombo FM, Bagnoli A, Vianello F, Gonovi F, et al. Gn-Rh agonist treatment before total laparoscopic hysterectomy for large uteri. J Am Assoc Gynecol Laparosc. 2003;10(3):316-9. 81.Blackwell R. Pretreatment with agonists/antagonists of any value? Program and abstracts from the 3er .World Congress on controversies in obstetrics. Ginecology & infertility [monograph on the Internet]. Washintong. DC; 2003 [cited 2006 Feb 2]. Available from: http://www.medscape.com/viewarticle/4384487 82.Rodríguez Hidalgo N. Miomectomía. En: Cirugía ginecológica y obstetricia. La Habana: Pueblo y Educación; 1993. p.198-211. 83.Mishell DR, Stenchever M, Droegemueller W, Herbst AL. Lesiones ginecológicas benignas. En: Tratado de ginecología. Madrid: Harcourt Brace de España; 1999. p. 465-515. 84.Vercauf BS. Myomectomy for fertility enhancement and preservation. Fertil Steril. 1992;58(1):15-21. 85.Fauconnier A, Dubuisson JB, Ancel P, Chapron C. Prognosis factors of reproductive autcome after myomectomy in infertility patients. Hum Reprod. 2000;15(8):1751-7. 86.Chaker A, Ferchiov M, Lahmar MM, Zhiona F, Meriach S. Uterine fibromyomas fertility after myomectomy. About 41 cases. Tunis Med. 2004;82(12):1075-81. 87.Seracchiooli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulleti C, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata. A randomized comparison with abdominal myomectomy. Human Reprod. 2000;15(2):2663-8. 88.Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Surv. 2001;66(3):483-9. 89.Varcellini P, Maddalena S, de Giorgio O, Pesole A, Ferrari L, Crosignani PG. Determinate of reproductive outcome after abdominal myomectomy for infertility. Fertil Steril. 1999;72(1):109-14. 90.Dessolle L, Soriano D, Poncelet C, Benifla JL, Madelanat P, Darai E. Determinats of pregnancy rate and obstetric outcome after laparoscopic myomectomy for infertility. Fertil Steril. 2001;76(2):370-4. 91.Frederick J, Hardiem M, Reid M, Iletcher H, Wynter S, Frederick C. Operative morbidity and reproductive outcome in secondary myomectomy: a prospective cohort study. Hum Reprod. 2002;17(11):2967-71. 92.Campo S, Campo V, Gambadauro P. Reproductive outcome before and after laparoscopic abdominal myomectomy for subserous or intramural myomas. Eur J Obstet Gynecol Reprod Biol. 2003;110(2):45-9. 93.Marchionni M, Fambrini M, Zambelli V, Scarcelli G, Sussini T. Reproductive performance before and after abdominal myomectomy: a retrospective analysis. Fertil Steril. 2004;82(1):154-9. 94.Hart R, Khalat Y, Yeon Ch, See P, Taylor A, Braude P. A prospective controlled study of the effect of intramural uterine fibroids on the outcome of assisted conception. Hum Reprod. 2001;16(11):2411-7. 95.Rackow BW, Arici A. Fibroids and in vitro fertilization: which come first ? Curr Opin Obstet Gynecol. 2005;17(3):225-31. 96.Hanafi M. Predictor of leiomyoma recurrence after myomectomy. Obstet Gynecol. 2005;105(14):877-81. 97.Stewart EA, Faur AV, Wise LA. Predictors of subsequent surgery for uterine leimyomatas after abdominal myomectomy. Obstet Gynecol. 2005; 99(8):426-32. 98.Olufowobi O, Sharik K, Papaionnous S, Noelakantan D, Mohammed H, Afnan M. Are the anticipated benefits of myomectomy achieved in women of reproductive age? A 5- year review of the results at a UK tertiary hospital. J Obstet Gynecol. 2004;24(4):434-40. 99.Becker ER, Spalding J, Duchane J, Horowitz IR. Impatient surgical treatment patterns whit uterine fibroid in the United States, (1998-2002). J Natl Med Assoc. 2005;97(10):1336-42. 100.Myers ER, Barber MD, Gustillo-Ashby T, Couchman G, Matchar DB, Mc Crory DC. Management of uterine leyomyomata. What do we really Know?. Obstet Gynecol. 2002; 100(1):8-17. 101.Kumar V, Abbas A, Fausto N. Renovación y reparación tisular, regeneración curación y fibrosis. En: Robbins SL, Cotran RS. Patología estructural y funcional. Madrid: Elsevier; 2005. p. 87-9. 102.Arce Bustabad S. Inmunología en las enfermedades quirúrgicas. En: García Gutiérrez A, Pardo Gómez G. Cirugía. Selección de temas. La Habana: Ciencias Médicas; 2003. p. 82-99. 103.Cunninghan FG, Mc Donald PC, Leveno KJ, Bloom SL, Hauth JC, Gilstrap III LC, Westron K. Anatomia y Fisiología del embarazo. En: Willians obstetricia. 22A ed. Mc Graw- Hill Interamericana. 2005. p. 15-151. 104.Horinchi A, Nikaido T, Yozhizawa T, Itoh K, Kohayashi Y, Toki T, et al. HCG prometes proliteration of uterine leiomyomal cells more strongly than that of myometrial smooth muscle cell in vitro. Mol Hum Reprod. 2000;6(6):523-8. 105.Ancellin M, Buteau-Lozano H, Meduri G, Osborne-Pellegrin M, Sordello S, Plovet J, et al. A dynamic shift of VEGF isoforms whith a transient and selective progesterone induced expression of VEGF 189 regulates angiogenesis and vascular permeability in human uterus. Proc Natt Acad Sci USA. 2002;99(9):6023-8. 106.Nardo LG. Vascular endothelial growth factor expression in the endometrium during the menstrual cycle implantation window and early pregnancy. Curr Opin Obstet Gynecol. 2005;17(4):419-23. 107.Laschke MW, Elitzsch A, Vollmar D, Vajkoczy P, Menger MD. Combined inhibition of vascular endothelial growth factor (VEGF) fibroblast growth factor, and platelet derived growth factor, but not inhibition of VEGF, alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod. 2005;19(3):506-10. 108.Matsumoto H, Nasu K, Nishida M, Ito H, Bing S, Miyakawa I. Regulation of proliferation motility and contractility of human endometrial stromal cells by platelet derived growth factor. Clin Endocrinol Metab. 2005;90(6):3560-7. 109.Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, Zhu L. Expression of vascular endothelial growth factor and trombospondin-1 mRNA in patients with endometriosis. Fertil Steril. 2002;78(1):148-53. 110.Wang DB, Zhang SL, Niu HY, Lu JM. Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase 9 gene expression in nude mouse endometriosis model. Zhonghua Fu Chan Ke Za Zhi. 2004;39(11):759-62. 111.Tsai SJ, Wu NH, Chen HM, Chuang PC, Wing LY. Fibroblast growth factor-9 is an endometrial stromal growth factor. Endocronology. 2002; 143(7):2715-21. 112.Taylor HS. Endometrial cell derived from donor stem cell in bone marrow transplantation recipients. JAMA. 2004;292:104-5. 113.Polan H, Yao MWM. Stem cell transfer and the uterus. The egge teaches the chicken. JAMA. 2004;292:81-5. 114.Liebermann-Meffert D. The greater omentum anatomy, embryology and surgical applications. Surg Clin North Am. 2000;80(1):275-93. 115.Van Vugt E, Van Rijthovenj EA, Kamperdijk EW, Beelen RH. Omental milky spots in the local immune response in the peritoneal cavity of rats. Acta Rec. 1996;224(2):235-6. 116.Shimotsuma M, Takahashi T, Kawata M, Dox K. Cellular subsets of the milky spoots in the human greater omentum. Cell Tissue Res. 1991;264(3):599-601. 117.Krist LF, Koenn H, Calame W, van der Harten JJ, van der Linden JC, Ecster Mans JJ, et al. Ontogeny of milky spoots in the human greater omentum: an inmuno chemical study. Anat Rec. 1997;249(3):399-404. 118.Beelen RH. The greater omentum. Physiology and immunological conceps. Neth J Surg. 1991;43(5):145-9. . 119.Fifth Annual Meeting of the International Federation of Adipose Therapeutics and Science (IFATS 2007). Stem Cells.2007; 25: 3274-3288. 120.Pinho M de F, Hurtado SP, El-Cheikh MC, Rossi MI, Dutra HS, Borojevic R. Myelopoiesis in the omentum of normal mice and during abdominal inflammatory processes. Cell Tissue. 2002;308(1):87-96. 121.Pinho M de F, Hurtado SP, El-Cheik Borojevic R. Haemopoietic progenitors in the adult mouse: permanent production of B lymphocites and monocytes. Cell Tissue Res. 2005;19(1):91-102. 122.Tatieschi-Yuyama E, Matsubara H, Murohara J, Ikeda V, Shintani S, Masaski H, et al. Therapeutic angiogenesis for patients with limb ischemia by autologous trasplantation of bone marrow cells: a pilot study and randomized controlled trial. Lancet. 2002;360:427-35. 123.Higashi Y, Kimida M, Hara K, Nomia K, Jitsuiki D, Nakagawa K, et al. Autologous bone marrow mononuclear cell implantation improve endothelium depent vasodilation in patient with limb ischemia. Circulation. 2004;109:1215-8. 124.Randal-Bollinger R. Autotransplantation. In: Sabiston AC. Tex book of surgery. The biological basis of moderm surgical practice. Philadelphia: WS Saunder Company; 2000. p. 497-528. 125.Litbarg N, Gudehithlu K, Sethupathi P, Arruda J, Dunea G, Singh A. "Activated omentum becomes rich in factors that promote healing and tissue regeneration ". Cell and Tissue Research. 2007; 328, (3): 487-497 126.Gallagher J, Webb A, Ilankovan V. Gastro omental free-flap in oral oropharingeal reconstruction: surgical anatomy, complications outcome. Br J Oral Maxillofac Surg. 2002;40(1):32-6. 127.Genden EM, Kaufman MR, Katz B, Vinea W, Urken MI. Tube gastro omental free-flap for pharingoesophageal reconstruction. Arch Otolaryngol Head Neck Sur. 2001;127(7):847-53. 128.De la Llera Domínguez G. Tratamiento preoperatorio y postoperatorio. En: García Gutiérrez A, Pardo Gómez G. Cirugía. Selección de temas. La Habana: Ciencias Médicas; 2003. p. 188-204. 129.Penchazadeh VB. Ética de las investigaciones biomédicas en un mundo globalizado. En: Acosta Sariego JR. Bioética para la sustentabilidad. La Habana: Centro Félix Valera; 2002. p. 440-53. 130.Ministerio de Salud Pública. Directrices sobre buenas prácticas clínicas. La Habana: CEDMED; 2000. 131.International Ethical Guidelines for Biomedical Research involving human subjects [monografía on the Internet]. Ginebra: CIOMS; 2002 [cited 2006 Sep 2]. Available from: http://www.cioms.ch/ethical.htm 132.González Cajals J. Manual de bioética clínica práctica. Madrid: Funden; 1998. 133.Hernández Ramírez P. Regeneración biológica. Secretos de la naturaleza. Rev Cubana Hematol Inmunol Hemoter [serie en Internet]. 2006 [6 Mar 2006]; 22(3):[aprox. 9 p.]. Disponible en: http://bvs.sld.cu/revistas/h.h/vol22_06/h.h02106.htm 134.Körbling M. Adult stem cell therapy. A new treatment modality? N Engl J Med. 2003;349:570-82. 135.Taylor A, Sharma M, Tsirkas P, Di Spiezio SA, Selchell M, Magos A. Reducing blood loss at open myomectomy using triple tourniquets: a ramdomised controlled trial. BJOG. 2005;112(3):340-5. 136.Pomés Correa C, Brañes Y, Cuellos Fredes M. Patología Cuerpo Uterino En: Cuello Fredes M Pomés Correa C. Atlas Ginecológico. Santiago de Chile. Grafic Suisse Seminario. 2006. p. 94-121 137.Lieng M, Istre O, Langebrekke A. Uterine rupture after laparoscopic myomectomy. Am Assoc Gynecol Laparosc. 2004;11(1):92-3. 138.Asakura H, Oda T, Tsumdda Y, Matsushima T, Kascki H, Takeshita T. A case report: change fetal heart rate pattern on spontaneous uterine rupture at 35 week gestation after laparoscopy. Assisted myomectomy. J Nippon Med Sch. 2004;7(1):69-72. 139.Oktem O, Gokaslan H, Dummusoglu F. Spontaneous uterine rupture in pregnancy 8 year after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 2001;8(4):618-21. 140.Malberti S, Ferrari L, Milani R. Spontaneous uterine rupture in the third trimester of gestation after laparoscopic myomectomy. A case report. Minerva Gynecol. 2004;56(5):479-80. 141.Matsunaga JS, Daly CB, Bochner CJ, Agnew CH. Repair of uterine dehiscence with continuation of pregnancy. Obstec Gynecol. 2005;105(6):1487-8. 142.West R, Ruiz R, Parker WH. Abdominal myomectomy in women with very large uterine size. Fertil Steril. 2006;85(1):36-9.